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Viridans streptococci can kill methicillin-resistant Staphylococcus aureus (MRSA) through the production of
hydrogen peroxide (H2O2). However, several hundred viridans streptococci cells are necessary to kill 1 cfu of
MRSA. We analyzed the potency of bactericidal and fungicidal effector molecules induced by catabolism of
H2O2 in the oral cavity. Secretory IgA (SIgA) and an unidentified salivary component bound Streptococcus
sanguinis, a viridans streprococcus, and MRSA into coaggregates. In these coaggregates, salivary peroxidase
and the MRSA catalase produced singlet molecular oxygen (1O2) from H2O2 produced by viridans streptococci.
SIgA converted 1O2 into ozone, which has potent bactericidal and fungicidal activity. We calculated that !10
cfu of Streptococcus sanguinis were necessary to kill 1 cfu of MRSA in the coaggregate. SIgA, Aspergillus niger
catalase, and H2O2 in saliva killed Candida albicans, which is highly resistant to reagent H2O2. Together with
indigenous bacteria and innate immunity, SIgA potentially constitutes a novel system that may sustain oral
homeostasis.
Early colonization by viridans streptococci prevents the
oral cavity of a newborn infant from being colonized
by methicillin-resistant Staphylococcus aureus (MRSA)
[1], suggesting that prevention of colonization relies on
hydrogen peroxide (H2O2) produced by viridans strep-
tococci. However, MRSA displays a strong catalase on
its surface, and a single viridans streptococcus cell pro-
duces insufficient H2O2 to kill MRSA [2]; concentration
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or augmentation of the bactericidal activity of H2O2 in
oral viridans streptococci is necessary for killing of
MRSA.
Coaggregation between MRSA and viridans strep-
tococci may compensate for the inadequate amount of
H2O2. Secretory IgA (SIgA) is the most abundant im-
munoglobulin produced against both commensal mi-
croorganisms [3] and pathogens [4], even in the saliva
of preterm infants [5, 6]. In addition to the 4 Fab bind-
ing sites [7, 8], glycan epitopes on the heavy chains and
the secretory component provide SIgA with further
bacteria-binding sites and possibly contribute to the
formation of coaggregates.
Salivary peroxidase [9, 10] and bacterial catalase [11]
may decompose the H2O2 produced by viridans strep-
tococci into harmless final products. It has been sug-
gested that, during its decomposition of H2O2, salivary
peroxidase produces singlet molecular oxygen (1O2) as
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Figure 1. Bacterial aggregation in vivo and in vitro. A, Aggregation in
the oral cavity of an infant. B, Aggregation after simple agitation of
Streptococcus sanguinis in saliva (macroscopic field). C, Absence of ag-
gregation in secretory IgA–depleted saliva. Aggregate, bacterial aggre-
gation; N, epithelial-cell nucleus.
Table 1. IgA concentration in saliva, and ability to aggregate Streptococcus sanguinis.
Source (age)
Colonizationa Initial isolation
Aggregationb
IgA in
saliva,
mg/mL Coaggregationc
Anti-MRSA
IgAdMRSA VS MRSA VS
Infant 1 (276 days) +  day 170 + 45  +
Infant 2 (84 days) +  day 4 + 88  
Infant 3 (90 days) +  day 2 + 24  
Infant 4 (49 days)  + day 15 + 26 + 
Infant 5 (6 days)  + day 3 + 12  
Infant 6 (133 days) + + day 113 day 133 + 4  
Adults e + f78.2 90.2 + +
NOTE. MRSA, methicillin-resistant Staphylococcus aureus; VS, viridans streptococci.
a First day of isolation during active surveillance.
b Ability of saliva to form VS aggregates.
c Ability of saliva to form coaggregates of viridans streptococci and MRSA.
d Analyzed by flow cytometry.
e 5 Adult volunteers.
f Mean  SD (not significantly different [ ] from that in the infants [ ]).Pp .406 33.030.4
a short-lived by-product [12]. If so, we would hypothesize that
1O2 is converted to ozone by the immunoglobulin-catalyzed
water-oxidation reaction, as recently described by Wentworth
et al. [13, 14], and that ozone has potent bactericidal activity.
In the present study, we examined the coaggregation between
MRSA and viridans streptococci and studied both (1) whether
the H2O2 produced by viridans streptococci in saliva is con-
verted to ozone and (2) whether it has bactericidal activity
against MRSA and fungicidal activity against Candida albicans.
MATERIALS AND METHODS
Saliva. Samples of unstimulated whole saliva were obtained
from 7 infants and from 5 healthy adult volunteers, by use of
a method described elsewhere [15]. All infants were inpatients
in the Neonatal Intensive Care Unit of Nagano Children’s Hos-
pital, and all were receiving mothers’ milk. Before the study,
formal permission was obtained from the hospital’s ethics com-
mittee, and informed consent was obtained from the parents
of each infant and from each adult volunteer.
Strains and growth conditions of microorganisms.
The microorganisms used were Streptococcus sanguinis
ATCC10556T, Streptococcus gordonii ATCC10558T, Streptococ-
cus oralis NCTC11427T, Streptococcus mitis NCTC12261T, cat-
alase-negative Staphylococcus aureus TW 4632, and clinical iso-
lates of Streptococcus sanguinis, C. albicans, and MRSA. These
strains were cultured on brain-heart infusion (BHI) broth (Nip-
pon Becton Dickinson). Identification and susceptibility test-
ing were accomplished by use of either MicroScan WalkAway
(Dade) or a method described elsewhere [16].
Depletion of IgA or IgG from saliva. SIgA or secretory
IgG was depleted from saliva by repeatedly passing the latter
through a monoclonal anti-IgA–coupled (Hytest) or anti-IgG–
coupled (Japan Biotest) affinity column (1 mL, HiTrap N-
hydroxy-succinimide–activated high performance; Amersham
Biosciences), until no residual antibodies were detected by
ELISA. The concentration of salivary IgA was determined by
use of a commercially available ELISA protein-detector kit (Kir-
kegaard & Perry Laboratories), according to the manufacturer’s
instructions.
Aggregation and coaggregation. Viridans streptococci,
MRSA (unstained or stained with ethidium bromide), or both
were mixed, on a glass slide for several minutes, with either intact
saliva, IgA- or IgG-depleted saliva, preadsorbed saliva (saliva ad-
sorbed with MRSA), or colostral SIgA (Cappel), and the aggre-
gates were observed macro- and microscopically. For study of
the formation of bacterial aggregates in vivo, oral cavities were
swabbed and were stained with May-Gru¨nwald-Giemsa solution.
Flow cytometry. MRSA ( cfu) was incubated, for 3071 10
min at room temperature, in either 0.5 mL of 50% saliva in
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Figure 2. Representative samples of fluorescence-activated–cell-sorter analyses of secretory IgA directed against methicillin-resistant Staphylococcus
aureus (anti-MRSA SIgA) in saliva. Except for that of infant 1, none of the saliva samples from infants contained anti-MRSA SIgA, although the
overall concentrations of SIgA were not significantly different from those in adults (see table 1). Infant 1 (9.2 months old) was colonized by MRSA
throughout the last 100 days of hospitalization and had very small amounts of anti-MRSA SIgA. Colostral SIgA contained anti-MRSA.
Figure 3. Coaggregation between Streptococcus sanguinis cells and
methicillin-resistant Staphylococcus aureus (MRSA) cells. MRSA cells
stained by ethidium bromide emit fluorescence in the coaggregate (A and
C ). Preadsorption of intact saliva with MRSA cells inhibited coaggregation,
although the ability of intact saliva to form S. sanguinis aggregates re-
mained (B and D ). Results of both fluorescent microscopy (A and B) and
light microscopy (C and D ) are shown.
PBS, 2 mg of colostral SIgA, or PBS. After being washed in
PBS, MRSA was stained with rabbit F(ab)′2 anti–human IgA
conjugated to fluorescein isothiocyanate (Dako) and were fixed
with 2% paraformaldehyde. A total of ∼104 cells were counted
in a gated region comprising unclamped cells, by use of a
FACScan (Becton Dickinson).
2-Dimensional gel electrophoresis, and analysis by matrix-
assisted laser-desorption ionization time-of-flight mass spec-
trometry (MALDI TOF MS) analysis. Proteins were analyzed
according to the method described by Yao et al. [17]. A 2-mL
aliquot of Streptococcus sanguinis cell sediments (a result of
centrifugation at 1300 g for 30 min at 4C) was incubated, for
60 min at room temperature, with 10 mL of saliva and was
washed 3 times with PBS. Salivary components bound to the
cell surface were extracted with 4 mol/L NaCl. Streptococcus
sanguinis proteins were extracted with a mixture of 8 mol/L
urea, 2 mol/L thiourea, and 4% 3-[(cholamidopropyl)di-
methylammonio]-1-propane sulfonate [18, 19]. The solvents
of these extracted proteins were replaced with either PBS or 8
mol/L urea, by use of a centrifugal filter device (Millipore).
Streptococcus sanguinis proteins bound to SIgA were prepared,
by use of a colostral SIgA–coupled affinity column. These pro-
teins were analyzed by 2-dimensional gel electrophoresis and
MALDI TOF MS (Applied Biosystems). Peptide-mass finger-
prints were used to screen tryptic-fragment libraries, by use of
Mascot (Matrix Sciences) and Protein Prospector (University
of California, San Francisco). All experiments were performed
3 times.
Assay of catalase activity. MRSA or C. albicans (100 mL)
was incubated in 2.9 mL of substrate solution (0.1 mL of 30%
H2O2 in 50 mL of 0.05 mol/L PBS [pH 7.0]), and the decrease
in absorbance at 240 nm at 25C was measured 2 times. One
catalase unit was defined as the amount that results in decom-
position at a rate of 1.0 mmol of H2O2/min by cfu, at
81 10
pH 7.0 and 25C [2].
Indigo carmine–oxidation reaction, in PBS and in saliva.
The method described by Wentworth et al. [14] was used to
Table 2. Mass-spectrometry data used for protein assignment, and proteins’ ability to bind to secretory IgA (SIgA) or Streptococcus sanguinis.
Protein assigned
Molecular weight, daltons
(isoelectric point)
Species with
homologous
protein
Peptide
matched Coverage, %
Bound to IgA-coupled
affinity columnObserved Theoretical
Translation elongation factor G 76,000 (4.8) 76,783 (4.86) S. pneumoniae 14 23 
dnaK protein 65,000 (4.3) 64,802 (4.6) S. pneumoniae 15 18 
Enolase 46,000 (4.4) 47,074 (4.70) S. pneumoniae 11 24 
Phosphoglycerate kinase 43,000 (4.8) 41,973 (4.86) S. pneumoniae 16 42 
Glyceraldehyde-3-phosphate dehydrogenase 39,000 (5.5) 38,739 (5.78) S. pneumoniae 10 23 
30S ribosomal protein S2 32,000 (4.9) 28,252 (5.11) S. pyogenes 11 48 
Fructose-bisphosphate aldolase 30,000 (5.0) 31,382 (5.00) S. pneumoniae 11 26 +a
Manganase-dependent dismutase 24,000 (4.8) 15,727 (4.81) S. sanguinis 6 46 + (a few)
Hepatocellular carcinoma–associated protein TB6 85,000 (6.0) 83,232 (5.58) Human 22 29 Bound to S. sanguinis cell surface
Immunoglobulin heavy-chain variant 62,000 (5.3) 44,758 (5.75) Human 10 27 Bound to S. sanguinis cell surface
a The most abundant protein that bound to the SIgA-coupled–affinity column.
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Figure 4. Decomposition of hydrogen peroxide (H2O2) in PBS. A, Decomposition by methicillin-resistant Staphylococcus aureus (MRSA) catalase (line
m) and spontaneous degradation when MRSA cells are absent (line s). B, Spontaneous degradation in the presence of indigo carmine (reactive to
singlet molecular oxygen [i.e., 1O2], O3, and H2O3). Very small but detectable amounts of oxidants were formed, some of which oxidized indigo carmine
(line s). MRSA catalase inhibited this oxidant formation, in a dose-dependent manner (line m1, cfu of MRSA [equivalent to the activity with52.5 10
1.4 mU of catalase]; line m2, cfu of MRSA [equivalent to the activity with 5.5 mU of catalase]). Overall, the comparative oxidant formation61.0 10
in these 3 situations, expressed in terms of the lines s, m1, and m2, was s 1 m1 ( ) and m1 1 m2 ( ). Aspergillus niger catalase (30P ! .02 P ! .04
mU) also inhibited oxidant formation (line c).
determine the indigo carmine–oxidation reaction. In each well
of a 96-well microtiter plate, 3 mL of indigo carmine (1 mmol/
L), which reacts with O3,
1O2, and H2O3, was mixed with a
solution of PBS (pH 7.4), 5 mL of MRSA in PBS at various
concentrations ( , , , and ),5 6 6 62.5 10 1.0 10 2.0 10 4.0 10
1 mL of 1% H2O2, and 91 mL of either PBS or saliva and was
incubated at 37C. At various time points, the decrease in ab-
sorbance at 600 nm was measured, 3 times, by use of a mi-
crotiter plate reader (Toso). In some experiments, various doses
(0.03–300 mU) of either Aspergillus niger catalase (Sigma-Al-
drich) or Staphylococcus aureus TW4632 (catalase-negativestrain)
were used instead of MRSA. To measure SIgA interference with
the reaction, 0, 0.5, or 2.0 mg of human colostral SIgA was
added to the reaction mixture comprising indigo carmine,
MRSA ( cfu), H2O2, and PBS. Each experiment was
52.5 10
performed 5 times.
Assay of 4-vinyl benzoic acid oxidation. The method de-
scribed by Wentworth et al. [14] was used to measure 4-vinyl
benzoic acid oxidation. Saliva (150 mL) was mixed with a so-
lution of 1 mmol/L of 4-vinyl benzoic acid, which reacts with
O3, in 150 mL of PBS (pH 7.4), 30 mL of 1% H2O2, and 1.1
mg of human colostral SIgA in 20 mL of PBS and was incubated
for 3 h at room temperature. Aliquots (20 mL) were removed
and diluted 1:3 in an acetonitrile:water (1:1) mixture. The prod-
uct composition was determined by reversed-phase high-per-
formance liquid chromatography performed by use of a Jasco
LC-800 apparatus (Nihon Bunko) with a Shim-Pack CLC-ODS
column. Products were detected by UV light at 254 nm (retention
time [RT] for 4-vinyl benzoic acid, 11.47 min; RT for 4-car-
boxybenzaldehyde, 3.83 min; RT for 4-oxiranyl-benzoic acid,
4.31 min). In the control assay, 4-vinyl benzoic acid was oxidized
by irradiation on a transilluminator (312 nm, 0.8 mW/cm2), at
room temperature in the presence of SIgA, and the composition
of the products was determined by a similar method.
Killing of MRSA by Streptococcus sanguinis. Killing of
MRSA by Streptococcus sanguinis was measured by use of 2
small (0.4 cm3) chambers separated by a dialyzing-cellulose
membrane (Wako Pure Chemical) made with silicon-rubber
sheets, between 2 glass slides. To 1 of these chambers, 41 10
cfu of MRSA in BHI broth was added; to the other chamber,
cfu of Streptococcus sanguinis was added; and both cham-65 10
bers were cultured for 16 h at 37C. Cells in each chamber were
recovered and were stained with 0.01% acridine orange in PBS
for 45 s and then were viewed under a fluorescence microscope
[20, 21]. In the control study, the same doses of MRSA were
cultured in a similar device but in only 1 chamber. SIgA’s aug-
mentation of the killing of MRSA by Streptococcus sanguinis was
measured. MRSA (25 mL, 230 cfu) was mixed with various doses
(200–3200 cfu) of Streptococcus sanguinis in intact, IgA- or IgG-
depleted saliva (125 mL), and the solution was incubated for 4
h at 37C. MRSA viability was measured on the basis of the rate
of recovery in the number of colony-forming units in ortho-
phthaldialdehyde/Staphylococcus medium (Nippon Becton Dick-
inson). These experiments were performed 3 times.
Killing of MRSA by Streptococcus sanguinis in 50% saliva–
agarose plates. MRSA (3 mL, cfu) in PBS was mixed81 10
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Figure 5. Decomposition of hydrogen peroxide (H2O2) in saliva. A, Decomposition by salivary peroxidase, which produced more indigo carmine–
reactive oxidant (line m0) than was produced in the spontaneous degradation (line s) ( ). B, Decomposition by methicillin-resistant StaphylococcusP ! .001
aureus (MRSA). At smaller doses ( cfu [line m1] and cfu [line m2) of MRSA, MRSA catalase increased the oxidant-producing activity5 62.5 10 1.0 10
of salivary peroxidase (line m0) (for m0 vs. m1, ); at larger doses ( cfu, equivalent to the activity with 11.0 mU of catalase [line m3]6P ! .02 2 10
and cfu, equivalent to the activity with 22.0 mU of catalase [line m4]), this activity was inhibited (for m0 vs. m4, ). C, Decomposition64 10 P ! .05
by Aspergillus niger. At 0.03 mU (line c1), A. niger catalase increased the oxidant-producing activity of salivary peroxidase (line m0) (for m0 vs. c1,
); at 0.3 mU (line c2), it had no effect; at 300 mU (line c3), it inhibited this activity (for m0 vs. c3, ). D, Staphylococcus aureus (catalase-P ! .003 P ! .001
negative strain TW4632) in saliva, which had no effect on the oxidant-producing activity of salivary peroxidase (line m0), at any of the 3 doses used
( cfu [line a1], cfu [line a2], and cfu [line a3).5 6 62.5 10 2.5 10 5 10
with 9 mL of BHI broth (preincubated for 10 min at 50C)
containing 50 mg of low-melting-point agarose (Takara) and
6 mL of saliva, and the solution was poured onto a plastic plate.
After the solution solidified, 3.3 mg of colostral SIgA (20 mL)
was spotted onto 3 points on the plate and was allowed to soak
into the gel, after which , , or cfu of Strep-8 7 61 10 1 10 1 10
tococcus sanguinis (ATCC10556T) (10 mL) were each spotted
onto 1 of these SIgA-soaked points; the same dose of Strep-
tococcus sanguinis solution, but without SIgA, was similarly
spotted onto 3 points on the plate. The plates were cultured
overnight at 35C in 5% CO2. This experiment was performed
2 times.
Killing of C. albicans by H2O2 in 50% saliva–agarose plates.
C. albicans ( cfu) was embedded in saliva/BHI-broth–81 10
agarose plates by use of the method described above, and co-
lostral SIgA was soaked into the gel. A. niger catalase (0.3 or
5.0 U) was spotted onto the points soaked with SIgA and onto
2 points not soaked with SIgA. Then, 1% H2O2 (10 mL) was
spotted onto the points soaked with SIgA, catalase, or both and
onto a point not soaked with either SIgA or catalase. The plate
was cultured overnight at 35C in 5% CO2. This experiment
was performed 2 times.
Statistical analysis. Student’s paired t test was used to
compare, at the 3 time points (30, 60, and 90 min), differences
in either the growth of MRSA cocultured with Streptococcus
sanguinis or the absorbance in the indigo carmine–oxidation
reaction. was considered to be significant.P ! .05
RESULTS
Aggregation and coaggregation. Figure 1A shows a represen-
tative sample of bacterial aggregate in the oral cavity of an
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Figure 6. Killing of methicillin-resistant Staphylococcus aureus (MRSA)
by Streptococcus sanguinis. Two small (0.4 cm3) chambers separated by
a dialyzing-cellulose membrane were constructed between 2 glass slides.
To 1 of these chambers, cfu of MRSA in brain-heart infusion41 10
broth was added; to the other chamber, cfu of Streptococcus65 10
sanguinis was added; and both chambers were cultured for 16 h at 37C.
Staining with acridine orange showed that the effector molecule(s) pro-
duced by Streptococcus sanguinis passed through the cellulose membrane
and killed MRSA cells in the neighboring chamber (A [no fluorescence]),
whereas Streptococcus sanguinis (B [orange fluorescence]), and MRSA
in a single-chamber device (C) survived; and MRSA cells killed by reagent
H2O2 did not emit fluorescence (D).
Figure 7. Survival of methicillin-resistant Staphylococcus aureus
(MRSA), in coaggregation between MRSA and Streptococcus sanguinis,
after incubation for 4 h. In the coaggregates formed in intact saliva,
incubation with S. sanguinis significantly decreased the survival of MRSA,
in a dose-dependent manner, compared with incubation of MRSA alone
( ). Initially, complete killing of 230 cfu of MRSA needed 17 timesP ! .001
(1600 cfu) the number of S. sanguinis. Although S. sanguinis decreased
the survival of MRSA similarly in IgA-depleted saliva, the recovery in the
rate of survival differed significantly ( ) in secretory IgA–depletedP ! .001
saliva vs. either intact or IgG-depleted saliva.
infant. Although the bacterial composition of this aggregate
was not determined, similar aggregates were easily formed in
vitro by simple agitation of viridans streptococci, either in saliva
(figure 1B) or in colostral SIgA (table 1). However, depletion
of IgA (figure 1C), but not of IgG, from saliva almost com-
pletely abolished aggregation. These data indicate that both
SIgA and viridans streptococci are important contributors to
bacterial aggregation in vivo. The concentration of IgA in the
7 infants’ saliva ( mg/mL) was not significantly dif-33.0 30.4
ferent from that in the 5 adults’ saliva ( mg/mL)78.2 90.2
( ) (see table 1); in contrast, none of the saliva andPp .406
none of the colostral SIgA formed MRSA aggregates, although
both saliva from the 5 adults and from 1 infant (infant 1) and
colostral SIgA contained anti-MRSA SIgA (figure 2). Coaggre-
gation between MRSA and Streptococcus sanguinis occurred in
the saliva of all 5 adults (figure 3A and 3C) and in that of 1
infant (infant 4, without anti-MRSA SIgA). The saliva of infant
1 contained anti-MRSA SIgA but did not form coaggregates
(see table 1). Preadsorption of the 5 adults’ saliva with MRSA
successfully inhibited coaggregation but not Streptococcus san-
guinis aggregation (figure 3B and 3D), which suggests that a
salivary component other than anti-MRSA SIgA is necessary
to bind viridans streptococci aggregates to MRSA.
Binding of salivary proteins to the Streptococcus sanguinis
cell surface and binding of colostral SIgA to S. sanguinis.
Salivary IgA and b-catenin bound to the cell surface of Strep-
tococcus sanguinis; of the cell-surface proteins of Streptococcus
sanguinis, fructose-bisphosphate aldolase and some manganese-
dependent dismutase bound to the SIgA-coupled affinity col-
umn (table 2).
Decomposition of H2O2 by bacterial cells, in PBS and in
saliva. The average catalase activity of 5 strains of MRSA was
U/ cfu; that of C. albicans was80.43 0.24 1 10 0.03
U/ cfu. In PBS, MRSA catalase decomposed H2O2
80.01 1 10
(figure 4A, line m), whereas reagent H2O2 remained stable (fig-
ure 4A, line s). Very small but detectable amounts of oxidants
were produced during the spontaneous degradation of H2O2
in the presence of indigo carmine (figure 4B, line s), and the
velocity of the reaction was proportional to the H2O2 concen-
tration (data not shown); MRSA catalase inhibited this oxidant
formation, in a dose-dependent manner (as shown by figure
4B, lines m1 [ cfu of MRSA, equivalent to the activity52.5 10
with 1.4 mU of catalase] and m2 [ cfu of MRSA,61.0 10
equivalent to the activity with 5.5 mU of catalase]; overall, the
comparative oxidant formation in these 3 situations, expressed
in terms of the lines in figure 4B, was s 1 m1 [ ] andP ! .02
m1 1 m2 [ ]). A. niger catalase (30 mU) also inhibitedP ! .04
this oxidant formation (figure 4B, line c). These data show that,
SIgA Conversion of H2O2 to O3 to kill MRSA • JID 2006:194 (1 July) • 105
Table 3. Killing of methicillin-resistant Staphylococcus aureus
(MRSA) by Streptococcus sanguinis, and killing of Candida al-
bicans by hydrogen peroxide in 50% saliva–agarose plate with
or without exogenous colostral secretory IgA (SIgA).
A. Killing of MRSA
S. sanguinis inoculated on plate
1  108 cfu 1  107 cfu 1  106 cfu
With SIgA (3.3 mg)a 57.8 3.1 49.9 1.6 13.5 2.1
Without SIgA 50.9 1.6 20.9 3.0 0
B. Killing of C. albicansb
Aspergillus niger catalase added to plate
0 units 0.3 units 5.0 units
With SIgA (3.3 mg)a 22.6 1.9 47.9 5.2 7.8 0.8
Without SIgA 0 0 0
NOTE. Data are mean  SD square millimeters of radii of clear zones in
which MRSA or C. albicans did not grow; around the clear zones, MRSA or
C. albicans culture produced confluent colonies.
a Exogenously added.
b Reagent hydrogen peroxide (10 mL, 1%), instead of S. sanguinis, was used.
in PBS, both A. niger catalase and MRSA catalase reduce the
bactericidal potency of H2O2.
Salivary peroxidase decomposed H2O2 and produced more
indigo carmine–reactive oxidant (figure 5A, line m0) than was
produced in the spontaneous decomposition of H2O2 (figure
5A, line s) ( ). However, in contrast to the oxidation-P ! .001
reaction outcome in PBS, MRSA in saliva did not always inhibit
the oxidant formation by salivary peroxidase: at smaller doses
( cfu [figure 5B, line m1] and cfu [figure5 62.5 10 1.0 10
5B, line m2) of MRSA, MRSA catalase increased the oxidant-
producing activity of salivary peroxidase (figure 5B, line m0)
(for m0 vs. m1, ); at larger doses ( cfu [equivalent6P ! .02 2 10
to the activity with 11.0 mU of catalase] [figure 5B, line m3]
and cfu [equivalent to the activity with 22.0 mU of cat-64 10
alase] [figure 5B, line m4]) of MRSA, this activity was inhibited
(for m0 vs. m4, ). For A. niger in saliva, the results wereP ! .05
similar: 0.03 mU (figure 5C, line c1) of A. niger catalase in-
creased the oxidant-producing activity of salivary peroxidase
(figure 5C, line m0) ( ), 0.3 mU of this catalase (figureP ! .003
5C, line c2) had no effect on this activity, and 300 mU of this
catalase (figure 5C, line c3) inhibited this activity ( ).P ! .001
Staphylococcus aureus (catalase-negative strain TW4632) in sa-
liva had no effect on the oxidant-producing activity of salivary
peroxidase, at any of the 3 doses used ( cfu [figure52.5 10
5D, line a1], cfu [figure 5D, line a2], and cfu6 62.5 10 5 10
[figure 5D, line a3).
SIgA-mediated interference with the indigo carmine–oxi-
dation reaction. After 180 min, exogenous SIgA (0.5 or 2.0
mg) decreased both the rate of the indigo carmine–oxidation
reaction by salivary peroxidase and the rate of the MRSA cat-
alase–catalyzed H2O2-decomposition reaction, by 11.9% and
28.6% ( ), respectively (data not shown). This resultP ! .001
suggests that SIgA mediates the production of an indigo car-
mine–nonreactive product, presumably the reformation of
H2O2. If so, then the indigo carmine–reactive components—
ozone and 1O2—are both products of the reaction. Next, we
tried to ascertain whether the reaction products included ozone.
Assay of 4-vinyl benzoic acid oxidation. Ozonolysis of 4-
vinyl benzoic acid was measured by reversed-phase high-per-
formance liquid chromatography. In the presence of SIgA and
saliva, H2O2 oxidized 4-vinyl benzoic acid (RT, 11.47 min) and
produced 4-carboxybenzaldehyde (RT, 3.83 min) and 4-oxi-
ranyl-benzoic acid (RT, 4.31 min), whereas neither H2O2 in
PBS nor SIgA and saliva without H2O2 oxidized it; and 4-vinyl
benzoic acid was similarly oxidized by ozone produced by UV
irradiation (data not shown). These data show that H2O2 is
decomposed by saliva and is converted to ozone by the catalytic
activity of SIgA.
Killing of MRSA by Streptococcus sanguinis. Staining
with acridine orange showed that the effector molecule(s) pro-
duced by Streptococcus sanguinis passed through the cellulose
membrane and killed MRSA in the neighboring chamber (fig-
ure 6A, no fluorescence), whereas Streptococcus sanguinis (figure
6B, orange fluorescence) and MRSA in a single-chamber device
(figure 6C) survived. MRSA killed by reagent H2O2 did not
emit fluorescence (figure 6D). SIgA augmented this bactericidal
activity of Streptococcus sanguinis. In the coaggregate (intact
saliva), Streptococcus sanguinis decreased the survival rate of
MRSA in a dose-dependent manner, compared with the rate
when MRSA was incubated alone ( ). Initially, completeP ! .001
killing of 230 cfu of MRSA required 17 times more (1600
cfu of) Streptococcus sanguinis (figure 7). However, Streptococcus
sanguinis decreased the survival rate of MRSA similarly in IgA-
depleted saliva; the survival rate of MRSA recovered completely
in SIgA-depleted saliva, whereas it did not recover in either
intact or IgG-depleted saliva ( ).P ! .001
Killing of MRSA by Streptococcus sanguinis and killing of
C. albicans by H2O2, in a 50% saliva–agarose plate. MRSA
cultured on a 50% saliva–agarose plate produced confluent
opaque colonies. Around the Streptococcus sanguinis colonies
without exogenous SIgA, MRSA was killed by cfu of81 10
Streptococcus sanguinis and by cfu of Streptococcus san-71 10
guinis, and the plate remained clear; however, MRSA was not
killed by cfu of Streptococcus sanguinis. To assess the61 10
level of killing, we compared the squares of the radii of the
clear zones. The addition of 3.3 mg of colostral SIgA, which
contained anti-MRSA SIgA (see figure 2), augmented the killing
of MRSA, and larger areas remained clear around Streptococcus
sanguinis at cfu, cfu ( ), and cfu8 7 61 10 1 10 P ! .001 1 10
( ) (table 3A).P ! .004
The data in table 3B show that very few C. albicans cells,
even those just below the spot of reagent H2O2 (10 mL, 1%),
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were killed in the absence of SIgA, even though the plate con-
tained saliva and A. niger catalase—and that the addition of
SIgA significantly augmented the killing. Large doses (5 U) of
A. niger catalase inhibited the killing of C. albicans, even in the
presence of SIgA, compared with the killing in cultures without
this catalase; however, large doses of this catalase did not com-
pletely eliminate production of 1O2, because the augmentation
in the killing of C. albicans in the presence of SIgA, compared
with the killing in the absence of SIgA, indicates that 1O2 is
present; and small doses (0.3 U) of the catalase augmented the
killing of C. albicans in the presence of SIgA, compared with
the level of killing in the absence of the catalase ( ).P ! .002
DISCUSSION
The data in the present study demonstrate a previously unrec-
ognized process that may help to maintain homeostasis in the
oral cavity and thereby defend the oral environment against
pathogens. Coaggregation between viridans streptococci and
pathogens, in conjunction with the catabolism of H2O2 in the
aggregates to produce ozone by SIgA, seems to be the key event
in this process. SIgA is responsible for mucosal defense, not
only by immune exclusion [22], but also by direct killing of
pathogens.
SIgA contains various bacteria-binding sites in its glycans,
in addition to its 4 Fab binding sites [7, 8], and it binds to
bacterial surface proteins, such as fructose bisphosphate al-
dolase of Streptococcus pneumoniae [23]. In fact, the present
study found that SIgA binds to viridans streptococci and forms
aggregates. However, such aggregation was not found when
MRSA was used, presumably because of the latter’s significant
z potential (i.e., the electrical potential of the interface between
the bacterial surface and the aqueous environment) [24], a
characteristic that is an advantage in the development of an
MRSA-killing process: even in the presence of anti-MRSA SIgA,
MRSA cells invading the oral cavity may remain unaggregated
until they associate with numerous viridans streptococci cells
[25] already aggregated to various extents. Additional salivary
component(s) that can reduce z potential may be necessary for
coaggregation; however, if such coaggregation occurs, z poten-
tial may augment bactericidal activity, even in infants’ saliva
without anti-MRSA SIgA.
Salivary peroxidase decomposes H2O2 into an indigo car-
mine–reactive oxidant, presumably either 1O2, O3, or H2O3 [12,
14]. However, this oxidant is not strong enough to kill some
resistant microorganisms, such as C. albicans [2]. In the present
study, the addition of SIgA and small doses of A. niger catalase
significantly augmented this oxidant’s bactericidal and fungi-
cidal effects, and more C. albicans cells were killed by the newly
synthesized oxidant. Ozone may be produced by the SIgA-
catalyzed water-oxidation reaction [14]. If so, then the oxidant
produced before the addition of SIgA is 1O2, one of the starting
materials of the reaction [12], and the products of 4-vinyl ben-
zoic acid oxidation strongly suggest that ozone is present [14].
In this situation, MRSA catalase may potentiate not the survival
but, instead, the suicide of MRSA.
None of the viridans streptococci tested in our earlier study
were low-H2O2–producing strains [2]; and the present study
used physiological amounts of SIgA, A. niger catalase, and re-
agent H2O2. In the present study, the concentration of SIgA
that was soaked into the plates was 5 times greater than that
in intact saliva, and this concentration may be achieved by the
coaggregation formation even in infants. Similarly, the con-
centrations of H2O2 and A. niger catalase were equivalent to
the amounts produced by cfu of either viridans strep-81 10
tococci [25] or MRSA and may be achievable in the oral cavity
[2]. Ozone may be toxic to oral epithelia [26]; however, because
it is short lived [14], tissue damage is limited to a narrow region
around the coaggregates. In BHI broth, 1500 viridans strep-
tococci cells are necessary to kill 1 MRSA cell [2], whereas the
results of the present study show that only 7 viridans strep-
tococci cells are necessary to kill each MRSA cell in the coag-
gregates. Therefore, the killing of MRSA and of C. albicans may
actually occur in the oral cavity. Mucosal surfaces other than
the oral cavity, such as the vaginal mucosa, which harbors H2O2-
producing lactobacilli, may have a similar system to destroy
pathogens [27].
In conclusion, the results of the present study show that, in
cooperation with H2O2-producing viridans streptococci and sal-
ivary components, SIgA can kill MRSA and C. albicans—and
that this killing potential is augmented by bacterial catalase.
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